Dana-Farber News

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Dana-Farber News
Dec 18, 2024, 18:09 | Blog
Narjust Florez: Our EQUAL study is about to launch
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist…
Sep 14, 2024, 15:42 | Blog
Lauren Merz: A brilliant piece on a nuanced subject that impacts millions of people
Lauren Merz, Hemat/onc fellow at Dana-Farber Institute, shared a post on X: "Cheers to STAT News…
Jun 27, 2024, 20:12 | Blog
Dana-Farber News - Biagio Ricciuti receives IASLC 2024 Young Investigator Grant
Dana-Farber News shared on X: "Congratulations to Biagio Ricciuti, who is a recipient of the IASLC…
Jun 26, 2024, 15:13 | Blog
Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura
Toni Choueiri shared a post by Kosuke Takemura, Staff Urologist at Ganken Hospital, on X: "Our new…
Jun 14, 2024, 15:36 | Blog
Direct Connect Partnership with Massachusetts Firefighters at Dana-Farber
Dana-Farber News made the following post on X: "Dana-Farber announces the launch of the Direct…
May 31, 2024, 15:41 | Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
Apr 20, 2024, 01:23 | Positive
Stuart H. Orkin was named one of TIME's 100 Most Influential People of 2024 - Dana-Farber News
Quoting Dana-Farber News on X/Twitter: "Congratulations to Dana-Farber Cancer Institute's Stuart H. Orkin, MD, who…
Feb 8, 2024, 17:06 | Insight
Narjust Florez: Sexual health in lung cancer made it to the front page of ACS Journal Cancer!
Narjust Florez shared a post by ACS Journal Cancer, on X: A "Grandma! Sexual health…
Jan 28, 2024, 18:44 | Blog
Interim phase 1 results show HPN328 is well tolerated and clinically active for neuroendocrine carcinomas - Dana-Farber News
Dana-Farber News recently shared a post on their X/Twitter page: "ASCO GU24: Interim phase 1…
Dec 22, 2023, 14:31 | Blog
Matthew Davids is the recipient of The Leukemia and Lymphoma Society Clinical Scholar Achievement Award - Dana-Farber News
Dana-Farber News shared a post on their X/Twitter page: "Congratulations to Matthew Davids, who is…
Oct 5, 2023, 15:47 | Insight
New study by Cigall Kadoch, PhD at Dana Farber reveals the sequence-specific contributions of intrinsically disordered proteins known as IDRs, which are implicated in cancer. - Dana-Farber News
Sep 20, 2023, 18:14 | Insight
A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.
Quoting Dana-Farber News on X/Twitter: "Eli Van Allen, Jackson Nyman (Dana-Farber Cancer Institute) and Toni…
All: 12 Posts: 1 - 100
Special Coverage